India

'Preliminary Good News': Adar Poonawalla Reacts to AstraZeneca's Experimental Vaccine Showing Positive Results in Elderly

A test tube labelled with the Vaccine is seen in front of AstraZeneca logo in this illustration taken, September 9, 2020. REUTERS/Dado Ruvic/Illustration

A test tube labelled with the Vaccine is seen in front of AstraZeneca logo in this illustration taken, September 9, 2020. REUTERS/Dado Ruvic/Illustration

AstraZeneca Plc has not sought emergency authorization of the vaccine till now but a report in the Sun indicated that hospital in the UK has been asked to prepare in order to receive the vaccine.

In a positive development, AstraZeneca, the British drugmaker informed that an experimental Covid-19 vaccine being developed by the University of Oxford is producing an immune response in both younger and older adults.

“Findings on blood tests carried out on a subset of older participants echo data released in July that showed the vaccine generated robust immune responses in healthy adults ages 18 to 55," AstraZeneca said.

The Astra-Oxford vaccine candidate is one of several front-runners in the race for protection against the virus. The announcement has led to a wave of optimism as Europe is under the second wave of pandemic and countries like Indian had registered 79 lakh cases.

AstraZeneca Plc has not sought emergency authorization of the vaccine till now but a report in the Sun indicated that hospital in the UK has been asked to prepare in order to receive the vaccine.

The Times had earlier reported that the company could get the required clearances for its coronavirus vaccine candidate by Christmas in the UK. The report said that a full vaccine roll-out programme for the populace could be rolled out in six months', the green signal is expected by this year end. The vaccine candidate is called AZD1222 globally and Covishield in India.

After AstraZeneca announced that an immune response was being produced in both younger and older adults, Adar Poonawalla whose Serum Institute is developing Covidhield in India said " A lot of people were wondering and asking the question, will these early vaccines be effective for the elderly and most vulnerable, here is some preliminary good news." Poonwalla said on twitter sharing a news report that said that AstraZeneca is announcing that the vaccine is showing efficacy in older adults.

Covishield is in the phase 2 and 3 trials of the coronavirus vaccine. Serum Institute has announced that they are hoping that the vaccine will be ready by year end, though it will be market ready by March 2021.

Football news:

सख्तार से हार पर क्रूस: अंत में, हम वापस जीत सकते हैं कि विश्वास का अभाव
जिनेदीन जिदाने: मैं सेवानिवृत्ति के बारे में नहीं सोचता
लोको भी तीसरे स्थान खो दिया है । साल्जबर्ग 5 केंद्रीय रक्षकों के साथ टीम को कुचल दिया
रोनाल्डो गोल्डन पैर जीता-2020, अगनेल्ली-गोल्डन पैर प्रेस्टीज-2020
स्चर्ले और गोएट्ज चिकित्सा प्रयोजनों के लिए मारिजुआना का उत्पादन है कि एक कंपनी में निवेश करेगा
Mircea Lucescu: रोनाल्डो के साथ, जुवेंटस जिंदा आता है. क्रिस्टियानो करिश्मा है, यह एक निर्णायक खिलाड़ी है
एलिसन की वजह से एक हिप चोट करने के लिए अजाक्स के साथ नहीं खेलेंगे